A duloxetin hatása a β-aktin stresszválaszra patkány agyban

Translated title of the contribution: The effects of duloxetine on β-actin stress response in rat brain

Szücs Szabina, M. Pákáski, Domokos Ágnes, J. Kálmán, Kálmán Sára, Garab Dénes, B. Penke, Szabó Gyula, Z. Janka, Kálmán János

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Depression is a frequent prodromal symptom of Alzheimer's disease (AD). Stress factors play an important role in the etiopathology of both diseases, since increased corticosteroid levels caused by chronic stress indirectly induce neuronal damage. The aim of our experiments was to evaluate the changes induced by stress in the transcription of amyloid precursor protein (APP), mitogen activated protein kinase-1 (MAPK-1) and β-actin, of which the latest plays a leading role in synaptic plasticity. Additionally we intended to examine how duloxetine - a serotonin-norepinephrin reuptake inhibitor type antidepressant - would modify the stress-induced changes. Wistar rats were exposed to immobilization stress for five hours daily through 21 days, while part of the animals received 45 mg/bwkg of duloxetine. At the end of the third week total RNA was purified from the cortex and hippocampus. The amount of β-actin, APP and MAPK-1 mRNA was determined by real time PCR method. On protein level, semiquantitative measurement was performed by Western blot. The expression of β-actin mRNA in the animals exposed to stress was four times as intense as in the control group. The increase in the β-actin mRNA levels was repressed by the duloxetine treatment. In the case of APP and MAPK-1 no changes were detected. According to the Western blot results, the antidepressant treatment slightly, the drug along with the stress treatment strongly decreased the amount of the β-actin protein. Our findings indicate that antidepressant treatment with duloxetine could play a protective role against the chronic stress-induced changes in the nervous system, such as disorders of synaptic plasticity, and the consequent cognitive dysfunctions in case of both affective disorders and AD.

Original languageHungarian
Pages (from-to)301-307
Number of pages7
JournalNeuropsychopharmacologia Hungarica
Volume12
Issue number1
Publication statusPublished - Mar 2010

Fingerprint

Actins
Amyloid beta-Protein Precursor
Mitogen-Activated Protein Kinase 1
Antidepressive Agents
Brain
Neuronal Plasticity
Messenger RNA
Alzheimer Disease
Western Blotting
Prodromal Symptoms
Serotonin Uptake Inhibitors
Mood Disorders
Immobilization
Nervous System
Wistar Rats
Real-Time Polymerase Chain Reaction
Hippocampus
Adrenal Cortex Hormones
Proteins
Duloxetine Hydrochloride

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Neuropsychology and Physiological Psychology
  • Clinical Neurology

Cite this

Szabina, S., Pákáski, M., Ágnes, D., Kálmán, J., Sára, K., Dénes, G., ... János, K. (2010). A duloxetin hatása a β-aktin stresszválaszra patkány agyban. Neuropsychopharmacologia Hungarica, 12(1), 301-307.

A duloxetin hatása a β-aktin stresszválaszra patkány agyban. / Szabina, Szücs; Pákáski, M.; Ágnes, Domokos; Kálmán, J.; Sára, Kálmán; Dénes, Garab; Penke, B.; Gyula, Szabó; Janka, Z.; János, Kálmán.

In: Neuropsychopharmacologia Hungarica, Vol. 12, No. 1, 03.2010, p. 301-307.

Research output: Contribution to journalArticle

Szabina, S, Pákáski, M, Ágnes, D, Kálmán, J, Sára, K, Dénes, G, Penke, B, Gyula, S, Janka, Z & János, K 2010, 'A duloxetin hatása a β-aktin stresszválaszra patkány agyban', Neuropsychopharmacologia Hungarica, vol. 12, no. 1, pp. 301-307.
Szabina, Szücs ; Pákáski, M. ; Ágnes, Domokos ; Kálmán, J. ; Sára, Kálmán ; Dénes, Garab ; Penke, B. ; Gyula, Szabó ; Janka, Z. ; János, Kálmán. / A duloxetin hatása a β-aktin stresszválaszra patkány agyban. In: Neuropsychopharmacologia Hungarica. 2010 ; Vol. 12, No. 1. pp. 301-307.
@article{04fb5d235fc84a79a752d856b13cb35a,
title = "A duloxetin hat{\'a}sa a β-aktin stresszv{\'a}laszra patk{\'a}ny agyban",
abstract = "Depression is a frequent prodromal symptom of Alzheimer's disease (AD). Stress factors play an important role in the etiopathology of both diseases, since increased corticosteroid levels caused by chronic stress indirectly induce neuronal damage. The aim of our experiments was to evaluate the changes induced by stress in the transcription of amyloid precursor protein (APP), mitogen activated protein kinase-1 (MAPK-1) and β-actin, of which the latest plays a leading role in synaptic plasticity. Additionally we intended to examine how duloxetine - a serotonin-norepinephrin reuptake inhibitor type antidepressant - would modify the stress-induced changes. Wistar rats were exposed to immobilization stress for five hours daily through 21 days, while part of the animals received 45 mg/bwkg of duloxetine. At the end of the third week total RNA was purified from the cortex and hippocampus. The amount of β-actin, APP and MAPK-1 mRNA was determined by real time PCR method. On protein level, semiquantitative measurement was performed by Western blot. The expression of β-actin mRNA in the animals exposed to stress was four times as intense as in the control group. The increase in the β-actin mRNA levels was repressed by the duloxetine treatment. In the case of APP and MAPK-1 no changes were detected. According to the Western blot results, the antidepressant treatment slightly, the drug along with the stress treatment strongly decreased the amount of the β-actin protein. Our findings indicate that antidepressant treatment with duloxetine could play a protective role against the chronic stress-induced changes in the nervous system, such as disorders of synaptic plasticity, and the consequent cognitive dysfunctions in case of both affective disorders and AD.",
keywords = "β-actin, Alzheimer's disease, Amyloid precursor protein, Duloxetine, Immobilization stress, Mitogen activated protein kinase",
author = "Sz{\"u}cs Szabina and M. P{\'a}k{\'a}ski and Domokos {\'A}gnes and J. K{\'a}lm{\'a}n and K{\'a}lm{\'a}n S{\'a}ra and Garab D{\'e}nes and B. Penke and Szab{\'o} Gyula and Z. Janka and K{\'a}lm{\'a}n J{\'a}nos",
year = "2010",
month = "3",
language = "Hungarian",
volume = "12",
pages = "301--307",
journal = "Neuropsychopharmacologia Hungarica",
issn = "1419-8711",
publisher = "Hungarian Association of Psychopharmacology",
number = "1",

}

TY - JOUR

T1 - A duloxetin hatása a β-aktin stresszválaszra patkány agyban

AU - Szabina, Szücs

AU - Pákáski, M.

AU - Ágnes, Domokos

AU - Kálmán, J.

AU - Sára, Kálmán

AU - Dénes, Garab

AU - Penke, B.

AU - Gyula, Szabó

AU - Janka, Z.

AU - János, Kálmán

PY - 2010/3

Y1 - 2010/3

N2 - Depression is a frequent prodromal symptom of Alzheimer's disease (AD). Stress factors play an important role in the etiopathology of both diseases, since increased corticosteroid levels caused by chronic stress indirectly induce neuronal damage. The aim of our experiments was to evaluate the changes induced by stress in the transcription of amyloid precursor protein (APP), mitogen activated protein kinase-1 (MAPK-1) and β-actin, of which the latest plays a leading role in synaptic plasticity. Additionally we intended to examine how duloxetine - a serotonin-norepinephrin reuptake inhibitor type antidepressant - would modify the stress-induced changes. Wistar rats were exposed to immobilization stress for five hours daily through 21 days, while part of the animals received 45 mg/bwkg of duloxetine. At the end of the third week total RNA was purified from the cortex and hippocampus. The amount of β-actin, APP and MAPK-1 mRNA was determined by real time PCR method. On protein level, semiquantitative measurement was performed by Western blot. The expression of β-actin mRNA in the animals exposed to stress was four times as intense as in the control group. The increase in the β-actin mRNA levels was repressed by the duloxetine treatment. In the case of APP and MAPK-1 no changes were detected. According to the Western blot results, the antidepressant treatment slightly, the drug along with the stress treatment strongly decreased the amount of the β-actin protein. Our findings indicate that antidepressant treatment with duloxetine could play a protective role against the chronic stress-induced changes in the nervous system, such as disorders of synaptic plasticity, and the consequent cognitive dysfunctions in case of both affective disorders and AD.

AB - Depression is a frequent prodromal symptom of Alzheimer's disease (AD). Stress factors play an important role in the etiopathology of both diseases, since increased corticosteroid levels caused by chronic stress indirectly induce neuronal damage. The aim of our experiments was to evaluate the changes induced by stress in the transcription of amyloid precursor protein (APP), mitogen activated protein kinase-1 (MAPK-1) and β-actin, of which the latest plays a leading role in synaptic plasticity. Additionally we intended to examine how duloxetine - a serotonin-norepinephrin reuptake inhibitor type antidepressant - would modify the stress-induced changes. Wistar rats were exposed to immobilization stress for five hours daily through 21 days, while part of the animals received 45 mg/bwkg of duloxetine. At the end of the third week total RNA was purified from the cortex and hippocampus. The amount of β-actin, APP and MAPK-1 mRNA was determined by real time PCR method. On protein level, semiquantitative measurement was performed by Western blot. The expression of β-actin mRNA in the animals exposed to stress was four times as intense as in the control group. The increase in the β-actin mRNA levels was repressed by the duloxetine treatment. In the case of APP and MAPK-1 no changes were detected. According to the Western blot results, the antidepressant treatment slightly, the drug along with the stress treatment strongly decreased the amount of the β-actin protein. Our findings indicate that antidepressant treatment with duloxetine could play a protective role against the chronic stress-induced changes in the nervous system, such as disorders of synaptic plasticity, and the consequent cognitive dysfunctions in case of both affective disorders and AD.

KW - β-actin

KW - Alzheimer's disease

KW - Amyloid precursor protein

KW - Duloxetine

KW - Immobilization stress

KW - Mitogen activated protein kinase

UR - http://www.scopus.com/inward/record.url?scp=77951548836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951548836&partnerID=8YFLogxK

M3 - Article

C2 - 20305306

AN - SCOPUS:77951548836

VL - 12

SP - 301

EP - 307

JO - Neuropsychopharmacologia Hungarica

JF - Neuropsychopharmacologia Hungarica

SN - 1419-8711

IS - 1

ER -